COMUNICADO: New Study With Victoza® (Liraglutide) Showed Improvements in Blood Glucose Control in Adults With Type 2 Diabetes Who Fa

Publicado 06/06/2015 16:01:14CET

2. Malmstrom H, Walldius G, Grill V, et al. Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohort. PLoS One. 2014; 9:e111463.

3. Lab Tests Online. Fructosamine testing. Available at: http://labtestsonline.org.uk/understanding/analytes/fructosamine/tab/test Accessed on: 23/05/2015.

4. Al-Arouj M, Assaad-Khalil S, Buse J, et al. Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care. 2010; 33:1895-1902.

5. Salti I, Benard E, Detournay B, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004; 27:2306-2311.

6. EMA. Victoza(R) EU Summary of Product Characteristics. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001026/WC500050017.pdf Last accessed 01.05.2015.

7. Internal Calculations based on IMS Midas Quantum data. March 2015.

8. FDA. Victoza(R) US prescribing information. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022341s018lbl.pdf Last accessed 01.05.2015.

Further Information

Media:

Katrine Sperling +45-4442-6718 krsp@novonordisk.com

Michael Bachner (US) +1-609-664-7308 mzyb@novonordisk.com

Investors:

Kasper Roseeuw Poulsen +45-3079-4303 krop@novonordisk.com

Melanie Raouzeos +45-3075-3479 mrz@novonordisk.com

Daniel Bohsen +45-3079-6376 dabo@novonordisk.com

Frank Daniel Mersebach (US) +1-609-235-8567 fdni@novonordisk.com

Mejora la comunicación de tu empresa con Europa Press Comunicación

Mejora la comunicación de tu empresa con Europa Press Comunicación